Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
20.76
+1.32 (6.79%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Cidara Therapeutics Employees
Cidara Therapeutics had 38 employees as of December 31, 2024. The number of employees decreased by 31 or -44.93% compared to the previous year.
Employees
38
Change (1Y)
-31
Growth (1Y)
-44.93%
Revenue / Employee
$33,553
Profits / Employee
-$4,469,132
Market Cap
227.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
CDTX News
- 5 days ago - Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors - GlobeNewsWire
- 20 days ago - Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 20 days ago - Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response - GlobeNewsWire
- 4 weeks ago - Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025 - GlobeNewsWire
- 5 weeks ago - Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology - GlobeNewsWire
- 6 weeks ago - Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer - GlobeNewsWire